T2* measurements of 3-T MRI with ultrashort TEs: Capabilities of pulmonary function assessment and clinical stage classification in smokers

American Journal of Roentgenology

Volumn 197, Issue 2, 2011, Pages

  Ohno, Yoshiharu ^a,b   Koyama, Hisanobu ^a   Yoshikawa, Takeshi ^a   Matsumoto, Keiko ^a,c   Takahashi, Masaya ^d   Van Cauteren, Marc ^e   Sugimura, Kazuro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY HOSPITAL   (Japan)

^c UNIVERSITY OF YAMANASHI   (Japan)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e PHILIPS HEALTHCARE   (United States)

Author keywords

Biomarkers; Chronic obstructive pulmonary disease (COPD); Lung; MRI; Pulmonary emphysema; T2*; Ultrashort TE

Indexed keywords

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; IMAGE ANALYSIS; LUNG CAPACITY; LUNG FUNCTION TEST; LUNG VOLUME; MALE; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SMOKING; CLASSIFICATION; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; HOSPITALIZATION; METHODOLOGY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RADIOGRAPHY;

AGED; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SMOKING; SOFTWARE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79960708224     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.5350     Document Type: Article

References (31)

1. Gewalt SL, Glover GH, Hedlund LW, Cofer GP, MacFall JR, Johnson GA. MR microscopy of the rat lung using projection reconstruction. Magn Reson Med 1993; 29:99-106 (Pubitemid 23063075)
2. Ramalho M, Herédia V, Tsurusaki M, Altun E, Semelka RC. Quantitative and qualitative comparison of 1.5 and 3.0 Tesla MRI in patients with chronic liver diseases. J Magn Reson Imaging 2009; 29:869-879
3. Lee VS, Hecht EM, Taouli B, Chen Q, Prince K, Oesingmann N. Body and cardiovascular MR imaging at 3.0 T. Radiology 2007; 244:692-705 (Pubitemid 47292080)
4. Merkle EM, Dale BM. Abdominal MRI at 3.0 T: the basics revisited. AJR 2006; 186:1524-1532 (Pubitemid 46112514)
5. Barth MM, Smith MP, Pedrosa I, Lenkinski RE, Rofsky NM. Body MR imaging at 3.0 T: understanding the opportunities and challenges. RadioGraphics 2007; 27:1445-1462
6. van den Bergen B, Stolk CC, Berg JB, Lagendijk JJ, Van den Berg CA. Ultra fast electromagnetic field computations for RF multi-transmit techniques in high field MRI. Phys Med Biol 2009; 54:1253-1264
7. Soher BJ, Dale BM, Merkle EM. A review of MR physics: 3T versus 1.5T. Magn Reson Imaging Clin N Am 2007; 15:277-290 (Pubitemid 47429999)
8. Togao O, Tsuji R, Ohno Y, Dimitrov I, Takahashi M. Ultrashort echo time (UTE) MRI of the lung: assessment of tissue density in the lung parenchyma. Magn Reson Med 2010; 64:1491-1498
9. Takahashi M, Togao O, Obara M, et al. Ultrashort echo time (UTE) MR imaging of the lung: comparison between normal and emphysematous lungs in mutant mice. J Magn Reson Imaging 2010; 32:326-333
10. Coxson HO, Rogers RM. Quantitative computed tomography of chronic obstructive pulmonary disease. Acad Radiol 2005; 12:1457-1463 (Pubitemid 41512839)
11. Hoffman EA, Simon BA, McLennan G. State of the art: a structural and functional assessment of the lung via multidetector-row computed tomography - phenotyping chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006; 3:519-532 (Pubitemid 44285543)
12. Naunheim KS, Wood DE, Krasna MJ, et al.; National Emphysema Treatment Trial Research Group. Predictors of operative mortality and cardiopulmonary morbidity in the National Emphysema Treatment Trial. J Thorac Cardiovasc Surg 2006; 131: 43-53 (Pubitemid 43049782)
13. Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD) - executive summary. Respir Care 2001; 46:798-825 (Pubitemid 33759920)
14. American Thoracic Society. Standardization of spirometry: 1987 update. Am Rev Respir Dis 1987; 136:1285-1298
15. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144:1202-1218
16. American Thoracic Society. Single breath carbon monoxide diffusing capacity (transfer factor): recommendations for a standard technique - statement of the American Thoracic Society. Am Rev Respir Dis 1987; 136:1299-1307
17. Hasegawa M, Nasuhara Y, Onodera Y, et al. Airflow limitation and airway dimensions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173:1309-1315 (Pubitemid 43900704)
18. Matsuoka S, Kurihara Y, Yagihashi K, Hoshino M, Nakajima Y. Airway dimensions at inspiratory and expiratory multisection CT in chronic obstructive pulmonary disease: correlation with airflow limitation. Radiology 2008; 248:1042-1049
19. Ohno Y, Koyama H, Matsumoto K, et al. Oxygen-enhanced MRI vs. quantitatively assessed thin-section CT: pulmonary functional loss assessment and clinical stage classification of asthmatics. Eur J Radiol 2011; 77:85-91
20. Ohno Y, Koyama H, Nogami M, et al. Dynamic oxygen-enhanced MRI versus quantitative CT: pulmonary functional loss assessment and clinical stage classification of smoking-related COPD. AJR 2008; 190:327; [web]W93-W99
21. Ohno Y, Iwasawa T, Seo JB, et al. Oxygenenhanced magnetic resonance imaging versus computed tomography: multicenter study for clinical stage classification of smoking-related chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177:1095-1102 (Pubitemid 351717568)
22. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-310 (Pubitemid 16134762)
23. Bland JM, Altman DG. Applying the right statistics: analyses of measurement studies. Ultrasound Obstet Gynecol 2003; 22:85-93 (Pubitemid 36886457)
24. Cutillo AG, Ganesan K, Ailion DC, et al. Alveolar air-tissue interface and nuclear magnetic resonance behavior of lung. J Appl Physiol 1991; 70:2145-2154
25. Hatabu H, Alsop DC, Listerud J, Bonnet M, Gefter WB. T2*and proton density measurement of normal human lung parenchyma using submillisecond echo time gradient echo magnetic resonance imaging. Eur J Radiol 1999; 29:245-252 (Pubitemid 29268376)
26. Boss A, Schaefer S, Martirosian P, Claussen CD, Schick F, Schaefer JF. Magnetic resonance imaging of lung tissue: influence of body positioning, breathing and oxygen inhalation on signal decay using multi-echo gradient-echo sequences. Invest Radiol 2008; 43:433-438 (Pubitemid 351769902)
27. Olsson LE, Lindahl M, Onnervik PO, et al. Measurement of MR signal and T2*in lung to characterize a tight skin mouse model of emphysema using single-point imaging. J Magn Reson Imaging 2007; 25:488-494 (Pubitemid 46355409)
28. Salerno M, de Lange EE, Altes TA, Truwit JD, Brookeman JR, Mugler JP 3rd. Emphysema: hyperpolarized helium 3 diffusion MR imaging of the lungs compared with spirometric indexes - initial experience. Radiology 2002; 222:252-260 (Pubitemid 34031496)
29. Fain SB, Korosec FR, Holmes JH, O'Halloran R, Sorkness RL, Grist TM. Functional lung imaging using hyperpolarized gas MRI. J Magn Reson Imaging 2007; 25:910-923 (Pubitemid 46697560)
30. Ohno Y, Hatabu H, Takenaka D, Van Cauteren M, Fujii M, Sugimura K. Dynamic oxygen-enhanced MRI reflects diffusing capacity of the lung. Magn Reson Med 2002; 47:1139-1144 (Pubitemid 34587405)
31. Jang YM, Oh YM, Seo JB, et al. Quantitatively assessed dynamic contrast-enhanced magnetic resonance imaging in patients with chronic obstructive pulmonary disease: correlation of perfusion parameters with pulmonary function test and quantitative computed tomography. Invest Radiol 2008; 43:403-410 (Pubitemid 351769898)